CSBR

Champions Oncology, Inc. (CSBR) Economic Moat Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Intangible Assets

Score: 6.2 (Moderate)

Champions Oncology’s intangible assets are moderately strong, anchored by its proprietary PDX models and specialized data. While these assets support client retention and pricing, the lack of broad patent protection and limited brand reach outside oncology research constrain the durability of this moat.

Network Effects

Score:

Champions Oncology benefits from modest network effects through its expanding data repository and research collaborations, but these are limited in scale and do not create significant barriers to entry or exponential value growth.

Switching Costs

Score:

Switching costs are moderate, as clients face some friction in changing providers due to integration and customization, but alternatives exist and barriers are not insurmountable.

Cost Advantage

Score:

While Champions Oncology operates efficiently, its cost structure does not provide a durable advantage over larger or better-capitalized competitors. Margins are healthy but not protected by scale.

Efficient Scale

Score:

Champions Oncology benefits from efficient scale in its niche, but the market is not immune to competition from larger CROs or new entrants with sufficient resources.

Overall Score

Score:

Champions Oncology possesses a moderate economic moat, supported by proprietary data assets, client integration, and niche market focus. However, the absence of strong patent protection, limited network effects, and exposure to competition from larger CROs constrain moat durability. The company’s efficient operations and recurring client relationships provide resilience, but barriers to entry are not high enough to ensure long-term excess returns without continued innovation and service differentiation.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Champions Oncology, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.